These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27406828)

  • 1. A Cell-Penetrating Peptide Targeting AAC-11 Specifically Induces Cancer Cells Death.
    Jagot-Lacoussiere L; Kotula E; Villoutreix BO; Bruzzoni-Giovanelli H; Poyet JL
    Cancer Res; 2016 Sep; 76(18):5479-90. PubMed ID: 27406828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anticancer peptide RT53 induces immunogenic cell death.
    Pasquereau-Kotula E; Habault J; Kroemer G; Poyet JL
    PLoS One; 2018; 13(8):e0201220. PubMed ID: 30080874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.
    Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
    Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53.
    Habault J; Kaci A; Pasquereau-Kotula E; Fraser C; Chomienne C; Dombret H; Braun T; Pla M; Poyet JL
    Oncoimmunology; 2020; 9(1):1728871. PubMed ID: 32158621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentation.
    Rigou P; Piddubnyak V; Faye A; Rain JC; Michel L; Calvo F; Poyet JL
    EMBO J; 2009 Jun; 28(11):1576-88. PubMed ID: 19387494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis.
    Aftabizadeh M; Li YJ; Zhao Q; Zhang C; Ambaye N; Song J; Nagao T; Lahtz C; Fakih M; Ann DK; Yu H; Herrmann A
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33491667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decursin from Angelica gigas Nakai Inhibits B16F10 Melanoma Growth Through Induction of Apoptosis.
    Kim BS; Seo H; Kim HJ; Bae SM; Son HN; Lee YJ; Ryu S; Park RW; Nam JO
    J Med Food; 2015 Oct; 18(10):1121-7. PubMed ID: 26336081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel peptide MT23 for potent penetrating and selective targeting in mouse melanoma cancer cells.
    Zhou N; Wu J; Qin YY; Zhao XL; Ding Y; Sun LS; He T; Huang XW; Liu CB; Wang H
    Eur J Pharm Biopharm; 2017 Nov; 120():80-88. PubMed ID: 28860066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting ATF5 in Cancer.
    Angelastro JM
    Trends Cancer; 2017 Jul; 3(7):471-474. PubMed ID: 28718401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.
    Heon Seo K; Ko HM; Kim HA; Choi JH; Jun Park S; Kim KJ; Lee HK; Im SY
    Cancer Res; 2006 May; 66(9):4681-6. PubMed ID: 16651419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus.
    Zhang T; Wu K; Ding C; Sun K; Guan Z; Wang X; Hsieh JT; He D; Fan J
    Oncotarget; 2015 Nov; 6(35):37782-91. PubMed ID: 26462022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting AAC-11 in cancer therapy.
    Faye A; Poyet JL
    Expert Opin Ther Targets; 2010 Jan; 14(1):57-65. PubMed ID: 20001210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-melanoma activity of Cynanchi atrati Radix is mediated by regulation of NF-kappa B activity and pro-apoptotic proteins.
    Son SW; Kim HG; Han JM; Lee JS; Choi MK; Lee JS; Son CG
    J Ethnopharmacol; 2014 Apr; 153(1):250-7. PubMed ID: 24583240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer effects of Ixeris dentata (Thunb. ex Thunb.) nakai extract on human melanoma cells A375P and A375SM.
    Lee HN; Shin SA; Choo GS; Kim HJ; Park YS; Park BK; Kim BS; Kim SK; Cho SD; Nam JS; Choi CS; Jung JY
    J Ethnopharmacol; 2016 Dec; 194():1022-1031. PubMed ID: 27836777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzofuroxan derivatives N-Br and N-I induce intrinsic apoptosis in melanoma cells by regulating AKT/BIM signaling and display anti metastatic activity in vivo.
    Farias CF; Massaoka MH; Girola N; Azevedo RA; Ferreira AK; Jorge SD; Tavares LC; Figueiredo CR; Travassos LR
    BMC Cancer; 2015 Oct; 15():807. PubMed ID: 26503030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models.
    Vallespí MG; Pimentel G; Cabrales-Rico A; Garza J; Oliva B; Mendoza O; Gomez Y; Basaco T; Sánchez I; Calderón C; Rodriguez JC; Markelova MR; Fichtner I; Astrada S; Bollati-Fogolín M; Garay HE; Reyes O
    J Pept Sci; 2014 Nov; 20(11):850-9. PubMed ID: 25044757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
    Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
    Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1.
    Gao Z; Shang Q; Liu Z; Deng C; Guo C
    Oncotarget; 2015 Nov; 6(34):36338-53. PubMed ID: 26462148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
    Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
    Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiomeric CopA3 dimer peptide suppresses cell viability and tumor xenograft growth of human gastric cancer cells.
    Lee JH; Kim IW; Shin YP; Park HJ; Lee YS; Lee IH; Kim MA; Yun EY; Nam SH; Ahn MY; Kang D; Hwang JS
    Tumour Biol; 2016 Mar; 37(3):3237-45. PubMed ID: 26432335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.